Spiro-Lactams as Novel Antimicrobial Agents.
To extend our previous studies on spirocyclic-β-lactams with anti-HIV and antiplasmodial properties to new spirocyclic-lactams in order to further explore structure-activity relationships. We have previously reported the synthesis of chiral spirocyclic-β-lactam derivatives via 1,3-dipolar cycloaddition of 6-diazopenicillanates with dipolarophiles. Spiro-2-pyrazoline-β-lactams were obtained from the reaction with acrylonitrile, acrylates or methyl vinyl ketone, whereas the reaction with N-substituted-maleimides afforded spiro-1-pyrazoline-β-lactams. Those studies led to the discovery of a lead compound with remarkable anti-HIV and antiplasmodial properties. The main objective of this work was to synthesize and evaluate the biologic activity of novel spiro-lactams based on previous identified lead compounds with antimicrobial activity. Synthetic Methodologies; Screening of anti-HIV antiplasmodial avtivity and antiplasmodial avtivity; Quantum chemical calculations. A novel synthetic route to chiral spiro-γ-lactams has been established. The studied β- and γ-lactams were not cytotoxic, and three compounds with promising antimicrobial activity were identified, whose structural modulation may lead to new and more potent drugs. The designed structural modulation of biological active spiro-β-lactams involved the replacement of the four-membered β-lactam ring by a five membered γ-lactam ring. Although, conformational and superimposition computational studies revealed no significant differences between β- and γ-lactam pharmacophoric features, the studied structural modulation did not lead to compounds with similar biological profile. The observed results suggest that the β-lactamic core is a requirement for the activity against both HIV and Plasmodium. Other: Quantum chemical calculations, at the DFT level of theory, were carried out in order to explore the structure and the preferred conformations of selected molecules.